[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Global & USA Multiple Sclerosis (MS) Drugs Market Research by Company, Type & Application 2015-2026

June 2021 | 105 pages | ID: CBEC5838F542EN
HeyReport

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

HeyReport estimates that the Multiple Sclerosis (MS) Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.

In this report, HeyReport discusses the Global & USA industrial policies, economic environment, and the impact of covid-19 on the Multiple Sclerosis (MS) Drugsindustry and its cost structure. Besides, this report covers the basic market dynamics, market size and companies competition data. In addition, the report also conducts basic market research on major product type, market end-use and regional trade.

Market Segment as follows:

Product Type Segmentation Includes
  • Copaxone (Glatiramer Acetate, Copolymer 1)
  • Novantrone (Mitoxantrone)
  • Gilenya (Fingolimod, Fty720)
  • Aubagio (Teriflunomide)
  • Tecfidera (Dimethyl Fumarate)
  • Firategrast (Sb683699, T-0047)
  • Siponimod (Baf312)
  • Others
Application Segmentation Includes
  • RRMS
  • SPMS
  • PPMS
  • PRMS
Companies Includes
  • Bayer AG
  • Bayhill Therapeutics
  • Biogen Idec
  • Cinnagen
  • Daiichi Sankyo
  • Eli Lilly
  • Fast Forward Llc
  • Antisense Therapeutics
  • Apitope
  • Five Prime Therapeutics
  • Genmab
  • Artielle Immunotherapeutics
  • Genzyme
  • Glaxosmithkline
  • Gw Pharmaceuticals
  • Innate Immunotherapeutics
The main contents of the report including:

Section 1:
Product definition, type and application, Global & USA market overview;
Section 2:
Global & USA Market competition by company;
Section 3:
Global & USA sales revenue, volume and price by type;
Section 4:
Global & USA sales revenue, volume and price by application;
Section 5:
USA export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
Industrial policies & economic environment
Section 9:
Conclusion.
For any other requirements, please feel free to contact HeyReport for customized contents.
1 MARKET OVERVIEW

1.1 Market Segment Overview
  1.1.1 Product Definition
  1.1.2 Market by Type
    1.1.2.1 Copaxone (Glatiramer Acetate, Copolymer 1)
    1.1.2.2 Novantrone (Mitoxantrone)
    1.1.2.3 Gilenya (Fingolimod, Fty720)
    1.1.2.4 Aubagio (Teriflunomide)
    1.1.2.5 Tecfidera (Dimethyl Fumarate)
    1.1.2.6 Firategrast (Sb683699, T-0047)
    1.1.2.7 Siponimod (Baf312)
    1.1.2.8 Others
  1.1.3 Market by Application
    1.1.3.1 RRMS
    1.1.3.2 SPMS
    1.1.3.3 PPMS
    1.1.3.4 PRMS
1.2 Global & USA Market Size & Forecast
  1.2.1 Global Market (2015-2020 & 2021-2026)
  1.2.2 USA Market (2015-2020 & 2021-2026)

2 GLOBAL & USA MARKET BY COMPANY

2.1 Global Sales by Company
2.2 USA Sales by Company

3 GLOBAL & USA MARKET BY TYPE

3.1 Global Sales by Product Type
3.2 USA Sales by Product Type

4 GLOBAL & USA MARKET BY APPLICATION

4.1 Global Sales by Application
4.2 USA Sales by Application

5 USA TRADE

5.1 Export Overview
5.2 Import Overview

6 KEY COMPANIES LIST

6.1 Bayer AG
  6.1.1 Company Information
  6.1.2 Product Specifications
  6.1.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Bayhill Therapeutics
  6.2.1 Company Information
  6.2.2 Product Specifications
  6.2.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Biogen Idec
  6.3.1 Company Information
  6.3.2 Product Specifications
  6.3.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Cinnagen
  6.4.1 Company Information
  6.4.2 Product Specifications
  6.4.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Daiichi Sankyo
  6.5.1 Company Information
  6.5.2 Product Specifications
  6.5.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Eli Lilly
  6.6.1 Company Information
  6.6.2 Product Specifications
  6.6.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Fast Forward Llc
  6.7.1 Company Information
  6.7.2 Product Specifications
  6.7.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Antisense Therapeutics
  6.8.1 Company Information
  6.8.2 Product Specifications
  6.8.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Apitope
  6.9.1 Company Information
  6.9.2 Product Specifications
  6.9.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Five Prime Therapeutics
  6.10.1 Company Information
  6.10.2 Product Specifications
  6.10.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Genmab
  6.11.1 Company Information
  6.11.2 Product Specifications
  6.11.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.12 Artielle Immunotherapeutics
  6.12.1 Company Information
  6.12.2 Product Specifications
  6.12.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.13 Genzyme
  6.13.1 Company Information
  6.13.2 Product Specifications
  6.13.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.14 Glaxosmithkline
  6.14.1 Company Information
  6.14.2 Product Specifications
  6.14.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.15 Gw Pharmaceuticals
  6.15.1 Company Information
  6.15.2 Product Specifications
  6.15.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.16 Innate Immunotherapeutics
  6.16.1 Company Information
  6.16.2 Product Specifications
  6.16.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)

7 INDUSTRY UPSTREAM

7.1 Industry Chain
7.2 Upstream Overview

8 POLICIES & MARKET ENVIRONMENT

8.1 Policies
  8.1.1 Major Regions Policies
  8.1.2 Policies in USA
8.2 Market Environment
  8.2.1 Porter's Five Forces
  8.2.2 Impact of COVID-19

9 RESEARCH CONCLUSION

LIST OF TABLES

Table Global Market Sales Revenue by Company 2015-2020
Table Global Market Sales Revenue Share by Company 2015-2020
Table Global Market Sales Volume by Company 2015-2020
Table Global Market Sales Volume Share by Company 2015-2020
Table Global Price by Company 2015-2020
Table USA Market Sales Revenue by Company 2015-2020
Table USA Market Sales Revenue Share by Company 2015-2020
Table USA Market Sales Volume by Company 2015-2020
Table USA Market Sales Volume Share by Company 2015-2020
Table USA Price by Company 2015-2020
Table Global Market Sales Revenue by Type 2015-2020
Table Global Market Sales Revenue Share by Type 2015-2020
Table Global Market Sales Volume by Type 2015-2020
Table Global Market Sales Volume Share by Type 2015-2020
Table Global Price by Type 2015-2020
Table USA Market Sales Revenue by Type 2015-2020
Table USA Market Sales Revenue Share by Type 2015-2020
Table USA Market Sales Volume by Type 2015-2020
Table USA Market Sales Volume Share by Type 2015-2020
Table USA Price by Type 2015-2020
Table Global Market Sales Revenue by Application 2015-2020
Table Global Market Sales Revenue Share by Application 2015-2020
Table Global Market Sales Volume by Application 2015-2020
Table Global Market Sales Volume Share by Application 2015-2020
Table Global Price by Application 2015-2020
Table USA Market Sales Revenue by Application 2015-2020
Table USA Market Sales Revenue Share by Application 2015-2020
Table USA Market Sales Volume by Application 2015-2020
Table USA Market Sales Volume Share by Application 2015-2020
Table USA Price by Application 2015-2020
Table USA Export 2015-2020 (Million USD)
Table USA Export 2015-2020 (Volume)
Table USA Import 2015-2020 (Million USD)
Table USA Import 2015-2020 (Volume)
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Bayer AG
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Bayhill Therapeutics
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Biogen Idec
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Cinnagen
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Daiichi Sankyo
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Eli Lilly
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Fast Forward Llc
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Antisense Therapeutics
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Apitope
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Five Prime Therapeutics
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Genmab
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Artielle Immunotherapeutics
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Genzyme
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Glaxosmithkline
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Gw Pharmaceuticals
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Innate Immunotherapeutics


LIST OF FIGURES

Figure Copaxone (Glatiramer Acetate, Copolymer 1) Market Size and Growth 2015-2020 (Million USD)
Figure Copaxone (Glatiramer Acetate, Copolymer 1) Market Size and Growth 2015-2020 (Volume)
Figure Copaxone (Glatiramer Acetate, Copolymer 1) Market Forecast and Growth 2021-2026 (Million USD)
Figure Copaxone (Glatiramer Acetate, Copolymer 1) Market Forecast and Growth 2021-2026 (Volume)
Figure Novantrone (Mitoxantrone) Market Size and Growth 2015-2020 (Million USD)
Figure Novantrone (Mitoxantrone) Market Size and Growth 2015-2020 (Volume)
Figure Novantrone (Mitoxantrone) Market Forecast and Growth 2021-2026 (Million USD)
Figure Novantrone (Mitoxantrone) Market Forecast and Growth 2021-2026 (Volume)
Figure Gilenya (Fingolimod, Fty720) Market Size and Growth 2015-2020 (Million USD)
Figure Gilenya (Fingolimod, Fty720) Market Size and Growth 2015-2020 (Volume)
Figure Gilenya (Fingolimod, Fty720) Market Forecast and Growth 2021-2026 (Million USD)
Figure Gilenya (Fingolimod, Fty720) Market Forecast and Growth 2021-2026 (Volume)
Figure Aubagio (Teriflunomide) Market Size and Growth 2015-2020 (Million USD)
Figure Aubagio (Teriflunomide) Market Size and Growth 2015-2020 (Volume)
Figure Aubagio (Teriflunomide) Market Forecast and Growth 2021-2026 (Million USD)
Figure Aubagio (Teriflunomide) Market Forecast and Growth 2021-2026 (Volume)
Figure Tecfidera (Dimethyl Fumarate) Market Size and Growth 2015-2020 (Million USD)
Figure Tecfidera (Dimethyl Fumarate) Market Size and Growth 2015-2020 (Volume)
Figure Tecfidera (Dimethyl Fumarate) Market Forecast and Growth 2021-2026 (Million USD)
Figure Tecfidera (Dimethyl Fumarate) Market Forecast and Growth 2021-2026 (Volume)
Figure Firategrast (Sb683699, T-0047) Market Size and Growth 2015-2020 (Million USD)
Figure Firategrast (Sb683699, T-0047) Market Size and Growth 2015-2020 (Volume)
Figure Firategrast (Sb683699, T-0047) Market Forecast and Growth 2021-2026 (Million USD)
Figure Firategrast (Sb683699, T-0047) Market Forecast and Growth 2021-2026 (Volume)
Figure Siponimod (Baf312) Market Size and Growth 2015-2020 (Million USD)
Figure Siponimod (Baf312) Market Size and Growth 2015-2020 (Volume)
Figure Siponimod (Baf312) Market Forecast and Growth 2021-2026 (Million USD)
Figure Siponimod (Baf312) Market Forecast and Growth 2021-2026 (Volume)
Figure Others Market Size and Growth 2015-2020 (Million USD)
Figure Others Market Size and Growth 2015-2020 (Volume)
Figure Others Market Forecast and Growth 2021-2026 (Million USD)
Figure Others Market Forecast and Growth 2021-2026 (Volume)
Figure RRMS Market Size and Growth 2015-2020 (Million USD)
Figure RRMS Market Size and Growth 2015-2020 (Volume)
Figure RRMS Market Forecast and Growth 2021-2026 (Million USD)
Figure RRMS Market Forecast and Growth 2021-2026 (Volume)
Figure SPMS Market Size and Growth 2015-2020 (Million USD)
Figure SPMS Market Size and Growth 2015-2020 (Volume)
Figure SPMS Market Forecast and Growth 2021-2026 (Million USD)
Figure SPMS Market Forecast and Growth 2021-2026 (Volume)
Figure PPMS Market Size and Growth 2015-2020 (Million USD)
Figure PPMS Market Size and Growth 2015-2020 (Volume)
Figure PPMS Market Forecast and Growth 2021-2026 (Million USD)
Figure PPMS Market Forecast and Growth 2021-2026 (Volume)
Figure PRMS Market Size and Growth 2015-2020 (Million USD)
Figure PRMS Market Size and Growth 2015-2020 (Volume)
Figure PRMS Market Forecast and Growth 2021-2026 (Million USD)
Figure PRMS Market Forecast and Growth 2021-2026 (Volume)
Figure Global Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2020 (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2020 (Volume)
Figure Global Multiple Sclerosis (MS) Drugs Market Forecast and Growth 2021-2026 (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Market Forecast and Growth 2021-2026 (Volume)
Figure USA Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2020 (Million USD)
Figure USA Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2020 (Volume)
Figure USA Multiple Sclerosis (MS) Drugs Market Forecast and Growth 2021-2026 (Million USD)
Figure USA Multiple Sclerosis (MS) Drugs Market Forecast and Growth 2021-2026 (Volume)
Figure Global Market Sales Revenue Share by Company in 2019
Figure Global Market Sales Volume Share by Company in 2019
Figure USA Market Sales Revenue Share by Company in 2019
Figure USA Market Sales Volume Share by Company in 2019
Figure Global Market Sales Revenue Share by Type in 2019
Figure Global Market Sales Volume Share by Type in 2019
Figure USA Market Sales Revenue Share by Type in 2019
Figure USA Market Sales Volume Share by Type in 2019
Figure Global Market Sales Revenue Share by Application in 2019
Figure Global Market Sales Volume Share by Application in 2019
Figure USA Market Sales Revenue Share by Application in 2019
Figure USA Market Sales Volume Share by Application in 2019
Figure Industry Chain Overview


More Publications